(S1 (S (NP (NP (NN Involvement)) (PP (IN of) (NP (NP (NN PKC)) (CC and) (NP (NN JNK)))) (PP (IN in) (NP (NN cytokine) (NN expression))) (. .))))
(S1 (S (S (NP (NN Jurkat) (NNS T-cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (NN PKC-)) (CC and) (NP (NN JNK))) (NNS inhibitors))) (PP (IN for) (NP (NP (CD 1) (NN h)) (VP (VBN followed) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN PMA)) (PRN (-LRB- -LRB-) (NP (CD 162) (NN nM)) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 24) (NN h))))))))))) (. .)))
(S1 (S (S (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN CXCL8) (NN expression)) (VP (VBD was) (VP (VBN inhibited) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))) (PP (IN by) (NP (DT both) (NNS inhibitors)))))) (. .)))
(S1 (S (S (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NN JNK-I)) (VP (VBD revealed) (NP (NP (DT a) (JJR stronger) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NN IL-6) (NN expression))) (PP (IN than) (NP (DT the) (NN PKC-I)))))) (. .)))
(S1 (S (S (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NN TNF) (NN expression)) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (DT either) (NN inhibitor)))))) (. .)))
(S1 (S (S (NP (NP (JJ Statistical) (NN significance)) (PP (IN from) (NP (NP (DT the) (JJ positive) (NN control)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN determined) (S (VP (VBG using) (NP (NP (NN Student) (POS 's)) (NN t-test))))))) (. .)))
(S1 (S (S (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 3)) (-RRB- -RRB-))) (. .)))
